Earnings Verdict
EOSE presents a high-volatility, low-liquidity earnings setup. The term structure shows a massive IV kink around the 4/10 and 4/17 expirations, suggesting an imminent event. The best strategy is a short premium play, capitalizing on extreme IV and historical under-movement, but sizing must be tiny due to wide spreads and gap risk.
base 5; -1 no explicit earnings date; -0.5 low liquidity; +0.5 extreme IV and clear term structure kink
Most important: Implied earnings date is 4/10-4/17 based on IV term structure kink. IV is astronomical (128% avg) and will crush post-event.
⚠️Earnings date is INFERRED from IV term structure kink, not explicitly provided. Date may be 4/10 or 4/17.
💰IV is in the 100%+ range. IV crush will be violent. Favor short premium strategies.
📉Extremely low liquidity. Use limit orders and tiny position sizes.
Regime Classification
Vol Regime
Extreme (IV 128%)
Gamma Regime
Pinning (GEX +$24.2M)
Flow Regime
Mixed (net prem -$0.2M, P/C 0.70)
Spot vs MP
Below max pain by 9.8% (spot $4.96 vs MP $6)
Gamma flip: ~$2.00 — Gamma flip ~$2 based on put OI concentration. Below $5, dealers are short gamma and may amplify moves lower.
Earnings Overview
Next earnings: 2026-04-10 (10 days)inferred_from_term_structure
Expected moves:
- 4/10 (10d): ±$0.64 (12.9%)
- 4/17 (17d): ±$0.90 (18.0%)
IV Setup
Term structure: Massive kink: 4/10 (97.5%) and 4/17 (104.7%) vs. 4/02 (88.7%). Peak IV at 4/24 (109.0%).
Crush estimate: ~30-40 vol pts post-earnings, back to ~70-80% range.
Skew: P/C OI ratio is 0.41, indicating heavy call OI. However, unusual put flow at $4 and $4.50 suggests downside hedging.
Historical Context
Beat rate: 25% (1/4 quarters)
Avg move vs expected: Insufficient data for direct comparison, but historical EPS surprises are volatile and often large misses.
Directional bias: No clear pattern from limited data.
Key Levels
1$5.00 (Max Pain 4/02, 4/10)
2$4.50 (Unusual Put Flow)
3$6.00 (Spot below by 9.8%)
4$2.00 (Major Put OI Wall, 43k)
Flow Highlights
Large $4.00 Call buying ($493K net prem) and $4.50 Put buying (2,838 vol vs 936 OI).
Contradictory signals: call buying for upside, put buying for protection near $4.50.
Massive OTM Put flow at $34, $30, $18, $15 (all net negative premium).
Likely far OTM put sales (premium collected) or hedging of long-dated positions, not direct earnings bets.
Strategies
Short Strangle (Post-IV Crush)
Sell $4.00 PUT / Sell $6.00 CALL, exp 4/17
Trigger: Enter 1-2 days AFTER earnings, once IV has crushed.
Avoids the massive IV crush. Collects premium in a still-elevated vol environment with defined risk zones based on key OI levels.
Outperforms: Stock consolidates between $4.50-$5.50 post-earnings.
Underperforms: Stock gaps beyond breakevens, especially below $4 given low price.
Put Credit Spread (Bullish Bias)
Sell $4.00 PUT / Buy $3.50 PUT, exp 4/17
Trigger: Enter day before inferred earnings date (4/9).
Defined risk. Targets the $4.00 support level evident in call flow and OI. Benefits from IV crush. Aligns with spot being below max pain, suggesting a potential pin or drift higher.
Outperforms: Stock stays above $4.00 post-earnings.
Underperforms: Stock closes below $3.85 on 4/17 expiration.
Long Straddle (Low Probability)
Buy $5.00 Straddle, exp 4/17
Trigger: Only if IV dips before earnings (unlikely).
The 4/17 expected move is $0.90 (18%). This strategy needs a move exceeding that to overcome IV decay. Given the extreme IV, the crush will be severe, making this a low-probability play. Included only as a cautionary example.
Outperforms: Stock moves >±18% ($0.90) from $5.00.
Underperforms: Stock moves less than ±18% and IV crushes massively.
Risk Assessment
!Gap Risk: High. Low-priced stock with 12.9-18% expected moves. A $1 move is a 20% change.
!IV Crush: Extreme. IV >100% will collapse, devastating long premium positions.
!Liquidity: Very Poor. Low volume, wide bid/ask spreads on options. Sizing must be minimal.
!Pin Risk: High. Spot at $4.96, with max pain at $5/$6 and major OI at $5.50 puts and $5 calls.
What to Watch
?Spot price action relative to $5.00 and $6.00 max pain levels.
?IV trajectory on the 4/10 and 4/17 expirations for confirmation of earnings timing.
?Any news confirming the Q1 2026 earnings date (estimated 4/10-4/17).